Position in SNY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$9,001,729
-$15,544,246 QoQ
Shares Held
211,011
-58.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#92
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $468,730,500 across 16 Drug Manufacturers - General names. SNY ranks #11 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
248,532 | $89,998,407 | |
| 2 | LLY |
ELI LILLY & Co
|
65,278 | $78,296,398 | |
| 3 | NVS |
Novartis AG
|
442,978 | $69,423,512 | |
| 4 | JNJ |
Johnson & Johnson
|
156,545 | $39,757,733 | |
| 5 | AZN |
Astrazeneca PLC
|
192,721 | $36,543,756 | |
| 6 | MRK |
Merck & Co., Inc.
|
252,444 | $32,439,054 | |
| 7 | ABBV |
AbbVie Inc.
|
123,655 | $31,116,544 | |
| 8 | GSK |
GSK plc
|
551,436 | $28,906,275 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,001,729 | 211,011 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $24,545,975 | 509,464 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $21,500,151 | 443,668 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $16,858,518 | 357,172 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $13,807,770 | 285,816 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $10,515,049 | 189,597 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $8,661,288 | 179,583 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,303,281 | 109,375 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $4,832,009 | 99,588 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,271,454 | 87,890 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,198,504 | 84,426 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,229,406 | 78,848 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $4,211,746 | 78,140 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,952,742 | 72,634 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $3,195,314 | 65,978 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,204,779 | 57,990 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,870,821 | 37,394 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $666,085 | 12,974 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $14,968,076 | 298,764 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,626,142 | 303,384 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $15,520,692 | 294,734 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,187,106 | 286,840 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,309,278 | 171,008 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $8,084,193 | 161,136 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,772,719 | 152,257 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $6,256,288 | 143,099 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||